Deep Track Capital, LP Madrigal Pharmaceuticals, Inc. Transaction History

Deep Track Capital, LP

  • $2.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$58.04 - $100.2 $6.91 Million - $11.9 Million
119,000 Added 15.14%
905,000 $64.8 Million
Q1 2022

May 16, 2022
BUY
$55.89 - $101.89 $16 Million - $29.1 Million
286,000 Added 57.2%
786,000 $77.1 Million
Q4 2021

Feb 14, 2022
BUY
$72.34 - $95.09 $36.2 Million - $47.5 Million
500,000 New
500,000 $42.4 Million

Others Institutions Holding MDGL

# of Institutions
298
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.9B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email